Statistics
Player Statistics
Every FPL player — points, price, form, ownership and upcoming fixtures. Filter by team and position.
Name | Fixtures | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| £5.5m | 49.8% | 75 | 4.0 | 13.6 | 0 | 2 | 4 | 8,553 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £15.8m | 78.6% | 72 | 3.5 | 4.6 | 2 | 9 | 0 | -25,881 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.3m | 49.4% | 70 | 3.0 | 11.1 | 0 | 4 | 6 | 7,862 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 11.4% | 70 | 4.8 | 13.2 | 0 | 1 | 2 | 8,655 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.1m | 26.6% | 67 | 8.0 | 8.3 | 1 | 1 | 0 | 4,809 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.5m | 26.3% | 67 | 7.5 | 10.3 | 6 | 6 | 4 | 33,826 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.7m | 32.7% | 66 | 6.0 | 9.9 | 8 | 5 | 1 | 21,471 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.1m | 18.3% | 63 | 8.0 | 12.4 | 6 | 2 | 0 | 17,924 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 11.4% | 62 | 4.2 | 12.9 | 4 | 2 | 1 | 8,758 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.3m | 47.7% | 61 | 4.8 | 9.7 | 1 | 0 | 0 | -9,252 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £9.3m | 26.3% | 61 | 4.8 | 6.6 | 0 | 7 | 0 | 14,896 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 48.6% | 58 | 3.5 | 9.8 | 1 | 1 | 2 | -1,352 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 25.5% | 58 | 8.2 | 11.8 | 1 | 1 | 0 | 1,600 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 6.8% | 58 | 6.0 | 11.4 | 2 | 0 | 2 | 10,909 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 24.3% | 57 | 4.8 | 12.1 | 0 | 0 | 0 | 4,661 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.2m | 54.6% | 57 | 4.2 | 7.0 | 5 | 5 | 2 | 7,781 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £7.2m | 35.9% | 56 | 8.8 | 7.8 | 2 | 6 | 1 | 20,484 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 3.5% | 56 | 8.8 | 10.0 | 14 | 0 | 1 | 9,585 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.2m | 18.8% | 56 | 2.5 | 9.0 | 0 | 1 | 1 | -2,895 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 6.8% | 56 | 6.0 | 11.2 | 2 | 0 | 0 | 10,964 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 16.6% | 55 | 5.5 | 8.2 | 5 | 3 | 1 | 2,175 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 11.5% | 55 | 6.8 | 9.6 | 0 | 6 | 1 | 1,467 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 2.5% | 55 | 5.2 | 12.2 | 4 | 1 | 0 | 2,170 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £7.9m | 33.3% | 55 | 2.8 | 7.0 | 1 | 5 | 2 | -36,908 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £7.5m | 13.7% | 51 | 3.8 | 6.8 | 1 | 0 | 5 | 1,585 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 4.7% | 51 | 3.5 | 10.0 | 0 | 2 | 3 | 1,767 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £6.0m | 5.6% | 51 | 4.8 | 8.5 | 7 | 3 | 3 | -2,030 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.7m | 7.2% | 50 | 3.8 | 7.5 | 0 | 3 | 1 | 669 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £9.8m | 28.0% | 49 | 2.8 | 5.0 | 2 | 3 | 4 | -10,505 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 1.6% | 49 | 5.8 | 10.0 | 10 | 3 | 2 | 6,587 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.7m | 13.3% | 49 | 2.5 | 10.4 | 0 | 0 | 0 | -1,074 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.7m | 3.1% | 49 | 6.2 | 8.6 | 3 | 3 | 1 | 1,607 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.1m | 3.9% | 48 | 6.8 | 9.4 | 8 | 0 | 0 | 2,569 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 8.8% | 48 | 2.2 | 9.1 | 0 | 3 | 3 | -3,850 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 16.5% | 48 | 3.8 | 8.0 | 9 | 4 | 2 | 14,500 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.8m | 9.3% | 47 | 1.5 | 8.1 | 0 | 3 | 4 | -5,648 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.6m | 28.5% | 47 | 0.0 | 6.2 | 0 | 5 | 3 | -23,880 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.2m | 16.9% | 47 | 3.0 | 9.0 | 1 | 1 | 1 | -5,288 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 15.9% | 47 | 6.0 | 10.7 | 7 | 0 | 0 | 3,598 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 12.1% | 46 | 1.5 | 7.5 | 0 | 3 | 2 | -6,390 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 2.5% | 46 | 3.8 | 8.4 | 0 | 3 | 1 | -196 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.3m | 7.0% | 46 | 5.2 | 6.3 | 0 | 1 | 5 | 10,216 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.8m | 17.9% | 46 | 1.2 | 5.9 | 0 | 4 | 1 | 448 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 4.9% | 45 | 4.2 | 8.2 | 1 | 2 | 4 | 1,936 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 20.2% | 45 | 1.0 | 8.0 | 1 | 1 | 4 | -28,816 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £11.6m | 20.0% | 45 | 3.0 | 3.9 | 0 | 4 | 2 | 2,375 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £7.8m | 5.6% | 45 | 2.0 | 5.8 | 0 | 1 | 4 | 1,727 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.7% | 44 | 2.5 | 9.8 | 0 | 0 | 1 | 115 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 1.2% | 44 | 4.0 | 9.8 | 0 | 0 | 2 | -327 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.1m | 4.8% | 44 | 3.5 | 8.6 | 0 | 0 | 0 | 915 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 4.8% | 44 | 5.2 | 8.0 | 0 | 0 | 0 | 2,576 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 2.0% | 44 | 7.5 | 9.2 | 11 | 0 | 0 | 576 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 2.2% | 43 | 3.0 | 7.8 | 0 | 0 | 0 | -117 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.7m | 0.5% | 43 | 5.2 | 7.5 | 15 | 4 | 0 | 21,084 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.4m | 14.4% | 43 | 3.5 | 6.7 | 0 | 0 | 0 | 879 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 4.0% | 42 | 2.5 | 7.8 | 0 | 0 | 3 | -2,482 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 3.9% | 42 | 3.0 | 9.3 | 0 | 1 | 0 | -754 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £6.6m | 4.8% | 42 | 2.0 | 6.4 | 1 | 3 | 1 | -5,451 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.6m | 2.5% | 42 | 3.5 | 9.1 | 0 | 0 | 1 | -345 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.2m | 11.7% | 42 | 3.0 | 10.0 | 0 | 1 | 0 | -1,891 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 4.1% | 42 | 3.0 | 7.6 | 0 | 0 | 0 | 904 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.2m | 8.8% | 41 | 2.8 | 6.6 | 1 | 2 | 3 | 2,536 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 1.5% | 41 | 3.0 | 9.1 | 0 | 1 | 0 | 38 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 4.3% | 41 | 3.8 | 9.1 | 2 | 0 | 0 | -417 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 1.4% | 41 | 3.0 | 7.6 | 1 | 1 | 1 | -662 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.5m | 0.5% | 41 | 5.5 | 7.5 | 6 | 1 | 1 | 902 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 2.8% | 41 | 3.2 | 7.6 | 2 | 2 | 1 | -1,509 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £7.8m | 8.9% | 41 | 2.8 | 5.3 | 2 | 1 | 3 | -1,868 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.4m | 5.8% | 40 | 4.2 | 5.4 | 5 | 3 | 1 | -414 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 40 | 6.0 | 6.8 | 9 | 2 | 2 | 4,407 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.3% | 40 | 3.8 | 7.3 | 12 | 2 | 3 | 313 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 1.1% | 40 | 5.2 | 7.3 | 2 | 2 | 2 | -261 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £7.1m | 7.0% | 40 | 2.0 | 5.6 | 0 | 1 | 3 | -228 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 3.4% | 39 | 6.0 | 7.2 | 6 | 0 | 1 | 558 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 1.7% | 39 | 1.5 | 7.1 | 0 | 2 | 1 | -767 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 8.4% | 39 | 2.8 | 7.1 | 0 | 0 | 0 | -349 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 5.3% | 39 | 2.8 | 6.7 | 2 | 0 | 4 | -4,217 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 12.5% | 39 | 0.5 | 6.6 | 2 | 1 | 1 | -5,249 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 3.5% | 39 | 4.2 | 6.3 | 10 | 1 | 1 | 1,798 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 2.9% | 39 | 4.2 | 9.1 | 1 | 0 | 2 | -1,140 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.6% | 38 | 2.0 | 7.6 | 2 | 1 | 3 | -294 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 6.4% | 38 | 1.8 | 9.3 | 0 | 0 | 0 | -1,848 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 1.7% | 38 | 5.5 | 6.9 | 0 | 2 | 3 | -129 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.7% | 38 | 3.8 | 7.2 | 7 | 0 | 2 | 105 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £9.4m | 5.2% | 37 | 0.0 | 3.9 | 0 | 3 | 0 | -1,842 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.4% | 37 | 3.2 | 7.4 | 3 | 0 | 1 | -53 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.1m | 3.4% | 37 | 2.8 | 7.3 | 6 | 0 | 0 | 3,533 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 1.6% | 37 | 1.8 | 7.4 | 0 | 2 | 0 | -421 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.2% | 37 | 3.0 | 8.2 | 1 | 0 | 1 | -103 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £8.2m | 5.3% | 37 | 0.0 | 4.5 | 0 | 2 | 3 | -1,923 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 1.4% | 37 | 4.5 | 7.0 | 8 | 0 | 0 | 45 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 3.3% | 36 | 5.2 | 8.0 | 6 | 0 | 0 | 577 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.5% | 36 | 3.8 | 8.0 | 4 | 0 | 0 | 290 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 5.8% | 35 | 2.8 | 7.0 | 0 | 0 | 0 | -590 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 6.9% | 35 | 1.0 | 8.8 | 3 | 0 | 0 | -1,081 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 2.7% | 35 | 1.2 | 6.5 | 1 | 2 | 1 | -1,498 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 7.0% | 35 | 1.5 | 6.5 | 2 | 0 | 0 | -3,507 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.4% | 35 | 2.8 | 7.0 | 5 | 2 | 1 | -180 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.9m | 4.9% | 35 | 3.0 | 7.1 | 1 | 1 | 1 | -1,904 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 2.0% | 35 | 2.0 | 6.4 | 0 | 0 | 1 | -393 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 6.4% | 34 | 2.5 | 7.6 | 0 | 1 | 0 | -1,212 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 4.5% | 34 | 1.5 | 7.7 | 1 | 2 | 0 | -1,641 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 4.4% | 34 | 1.5 | 8.3 | 0 | 1 | 0 | -621 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 1.6% | 34 | 0.8 | 5.7 | 1 | 1 | 0 | -294 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 1.9% | 34 | 2.2 | 6.4 | 0 | 0 | 1 | -1,914 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.3m | 2.5% | 33 | 4.5 | 5.2 | 3 | 1 | 0 | -189 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.4% | 33 | 3.0 | 5.6 | 10 | 2 | 2 | 416 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 1.2% | 33 | 3.5 | 7.5 | 1 | 0 | 0 | -255 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 2.3% | 33 | 2.0 | 6.2 | 0 | 0 | 1 | -2,888 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.4m | 5.6% | 32 | 2.0 | 5.9 | 0 | 0 | 2 | -1,645 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.1% | 32 | 3.2 | 6.4 | 1 | 0 | 1 | -36 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.2m | 1.6% | 32 | 4.5 | 7.6 | 5 | 0 | 0 | -158 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.7m | 4.1% | 32 | 2.0 | 5.6 | 0 | 3 | 1 | -5,625 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.6% | 31 | 5.5 | 6.3 | 3 | 2 | 2 | 1,399 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 31 | 3.5 | 6.9 | 3 | 0 | 0 | 10 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 2.4% | 31 | 1.0 | 7.8 | 0 | 0 | 1 | -796 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 2.7% | 31 | 1.8 | 7.8 | 3 | 1 | 0 | -453 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.6m | 1.1% | 31 | 1.8 | 5.5 | 0 | 1 | 1 | -116 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 1.1% | 31 | 3.8 | 6.2 | 1 | 0 | 0 | -306 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 1.7% | 31 | 4.5 | 5.8 | 1 | 3 | 0 | 243 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.1% | 31 | 3.2 | 5.6 | 4 | 0 | 0 | -23 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 4.0% | 31 | 3.0 | 6.2 | 0 | 0 | 0 | -1,389 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 30 | 5.2 | 4.8 | 8 | 2 | 1 | 892 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.7m | 2.1% | 30 | 2.2 | 4.5 | 2 | 2 | 0 | -715 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 30 | 0.5 | 5.1 | 1 | 1 | 1 | -441 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 2.1% | 30 | 0.0 | 5.1 | 0 | 1 | 2 | -18 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £7.8m | 6.7% | 30 | 3.0 | 3.8 | 0 | 2 | 3 | -6,491 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 1.4% | 30 | 1.2 | 7.5 | 0 | 1 | 1 | -410 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.5% | 30 | 2.5 | 6.1 | 3 | 0 | 0 | -56 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.3m | 0.6% | 30 | 2.2 | 5.7 | 1 | 0 | 1 | -124 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 0.5% | 30 | 2.2 | 5.5 | 0 | 1 | 1 | -152 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 30 | 3.5 | 6.0 | 3 | 0 | 0 | 6 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 30 | 3.5 | 6.7 | 4 | 0 | 0 | 56 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.5m | 2.0% | 30 | 1.5 | 5.5 | 2 | 0 | 0 | -719 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 1.1% | 30 | 1.0 | 5.5 | 0 | 0 | 1 | 33 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 0.5% | 30 | 1.2 | 5.5 | 1 | 2 | 0 | -238 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.6m | 2.5% | 30 | 3.5 | 4.5 | 2 | 0 | 3 | -891 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 29 | 4.8 | 6.4 | 6 | 0 | 0 | 147 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.3% | 29 | 3.2 | 5.8 | 3 | 0 | 0 | -19 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.3m | 1.2% | 29 | 0.2 | 6.7 | 0 | 0 | 0 | -200 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 1.3% | 29 | 1.5 | 5.9 | 2 | 2 | 1 | -779 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.3% | 29 | 2.8 | 6.0 | 4 | 0 | 1 | 36 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 6.3% | 29 | 0.8 | 7.2 | 1 | 2 | 2 | -3,012 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 1.1% | 29 | 2.5 | 7.2 | 0 | 1 | 3 | -93 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 29 | 2.5 | 6.4 | 1 | 0 | 1 | 65 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.3% | 29 | 3.0 | 5.9 | 2 | 0 | 2 | -18 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 13.4% | 29 | 2.0 | 4.3 | 0 | 1 | 1 | 616 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 1.0% | 29 | 4.0 | 6.6 | 0 | 0 | 2 | -318 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 1.3% | 29 | 2.8 | 5.0 | 7 | 2 | 1 | -162 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.8% | 28 | 2.0 | 6.2 | 2 | 0 | 1 | -198 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.3% | 28 | 2.2 | 5.6 | 0 | 0 | 1 | -103 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 28 | 2.2 | 5.6 | 3 | 0 | 0 | -14 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 5.0% | 28 | 4.8 | 5.3 | 12 | 0 | 1 | 2,984 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.6m | 0.7% | 28 | 4.8 | 5.0 | 4 | 0 | 1 | -19 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 28 | 4.5 | 6.4 | 6 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 28 | 3.2 | 5.8 | 3 | 0 | 0 | -35 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.9m | 0.2% | 27 | 1.2 | 4.6 | 0 | 1 | 2 | -93 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.9% | 27 | 2.0 | 5.4 | 4 | 0 | 3 | -429 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.2m | 0.1% | 27 | 2.8 | 5.2 | 1 | 2 | 1 | -17 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 1.4% | 27 | 3.2 | 5.0 | 0 | 1 | 0 | 104 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.5m | 0.6% | 27 | 0.2 | 4.2 | 0 | 2 | 1 | -121 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.5m | 4.4% | 27 | 2.0 | 3.6 | 2 | 1 | 2 | -5,303 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.7% | 27 | 0.2 | 5.4 | 1 | 1 | 0 | -173 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.2% | 27 | 3.0 | 6.1 | 6 | 0 | 1 | -12 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 26 | 1.5 | 5.8 | 0 | 0 | 0 | -453 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 0.4% | 26 | 4.2 | 4.2 | 0 | 1 | 1 | 32 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.1% | 26 | 0.0 | 5.8 | 0 | 1 | 1 | -498 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.2% | 26 | 3.2 | 5.9 | 1 | 1 | 0 | 27 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 2.5% | 26 | 6.0 | 6.7 | 6 | 0 | 1 | 411 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.0m | 0.1% | 25 | 3.8 | 5.0 | 3 | 0 | 1 | 20 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.6% | 25 | 0.8 | 4.2 | 0 | 3 | 0 | -116 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 2.5% | 25 | 0.8 | 5.7 | 0 | 2 | 0 | -1,313 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.5% | 25 | 1.5 | 5.6 | 0 | 0 | 3 | -418 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.5% | 25 | 2.8 | 5.6 | 1 | 0 | 0 | -25 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.0m | 0.2% | 25 | 2.0 | 4.2 | 0 | 0 | 0 | -63 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 3.1% | 25 | 1.8 | 4.3 | 1 | 1 | 0 | -2,379 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.6% | 25 | 2.0 | 6.2 | 0 | 0 | 0 | -37 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 1.8% | 25 | 2.2 | 4.7 | 0 | 0 | 0 | -151 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £8.1m | 4.4% | 25 | 3.0 | 3.1 | 0 | 0 | 3 | 1,105 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 1.3% | 25 | 2.5 | 5.1 | 7 | 1 | 0 | -236 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 1.3% | 25 | 1.8 | 5.0 | 2 | 0 | 0 | -240 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.0m | 2.5% | 25 | 1.8 | 3.6 | 1 | 1 | 0 | -4,177 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.2% | 25 | 2.8 | 5.1 | 1 | 1 | 0 | -82 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.2% | 24 | 2.8 | 4.8 | 1 | 1 | 1 | -41 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 4.2% | 24 | 0.8 | 4.1 | 0 | 0 | 1 | -2,035 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.2% | 24 | 0.8 | 4.8 | 1 | 1 | 0 | -77 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 4.2% | 24 | 1.5 | 5.3 | 0 | 0 | 1 | -1,252 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.9m | 3.5% | 24 | 1.8 | 3.5 | 1 | 1 | 0 | -2,520 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 24 | 2.2 | 4.4 | 0 | 0 | 1 | -58 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.6m | 0.3% | 24 | 3.8 | 4.3 | 0 | 1 | 0 | -1,234 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 3.8% | 23 | 1.8 | 3.8 | 1 | 0 | 2 | -664 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.1% | 23 | 4.8 | 4.6 | 0 | 1 | 1 | 66 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.8m | 2.1% | 23 | 1.2 | 3.4 | 2 | 1 | 2 | -1,229 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 2.2% | 23 | 1.2 | 3.8 | 1 | 2 | 0 | -241 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.9m | 7.5% | 23 | 1.2 | 3.9 | 1 | 1 | 1 | -4,115 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 0.4% | 23 | 4.5 | 4.0 | 5 | 1 | 2 | 161 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.4% | 22 | 0.0 | 4.9 | 0 | 0 | 1 | -115 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.3% | 22 | 3.5 | 4.4 | 2 | 0 | 1 | 102 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.2% | 22 | 2.2 | 5.5 | 3 | 1 | 0 | -5 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.2% | 22 | 1.2 | 4.2 | 1 | 1 | 0 | -47 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.9m | 0.9% | 22 | 0.8 | 3.7 | 0 | 0 | 0 | -659 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 0.1% | 22 | 4.5 | 3.7 | 1 | 1 | 1 | 80 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 0.1% | 22 | 1.0 | 4.4 | 0 | 1 | 1 | -40 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.2% | 21 | 2.0 | 4.7 | 8 | 0 | 0 | 425 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 3.0% | 21 | 0.2 | 4.3 | 1 | 0 | 0 | 175 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 6.8% | 21 | 2.0 | 5.4 | 1 | 0 | 1 | -837 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.1% | 21 | 4.2 | 4.4 | 7 | 2 | 0 | 192 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 0.3% | 21 | 4.2 | 3.9 | 5 | 2 | 0 | 44 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.3% | 21 | 4.2 | 4.0 | 8 | 2 | 0 | 474 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £3.9m | 9.6% | 21 | 1.0 | 5.4 | 0 | 0 | 0 | -1,751 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.1% | 21 | 3.8 | 4.4 | 1 | 1 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.5% | 21 | 2.0 | 4.2 | 0 | 0 | 0 | -88 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 7.0% | 21 | 1.2 | 4.4 | 0 | 0 | 0 | -1,041 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 21 | 2.8 | 3.7 | 0 | 1 | 2 | -38 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.7% | 21 | 1.0 | 3.9 | 2 | 1 | 1 | -144 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 20 | 2.2 | 4.1 | 1 | 0 | 1 | -40 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.1% | 20 | 0.8 | 3.6 | 0 | 1 | 1 | -8 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.9% | 20 | 2.2 | 4.2 | 0 | 0 | 0 | -263 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 20 | 1.2 | 4.2 | 1 | 0 | 0 | -20 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 20 | 0.8 | 4.0 | 2 | 0 | 1 | -6 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.2m | 0.1% | 20 | 1.8 | 3.8 | 1 | 1 | 1 | -13 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 1.2% | 20 | 2.5 | 3.8 | 2 | 0 | 0 | -145 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 1.0% | 19 | 3.5 | 3.1 | 10 | 1 | 0 | 55 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.3% | 19 | 0.5 | 3.6 | 0 | 0 | 1 | -31 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 19 | 3.5 | 4.2 | 0 | 0 | 0 | 41 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.1% | 19 | 1.5 | 4.0 | 0 | 0 | 0 | -80 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.4% | 19 | 1.2 | 3.8 | 1 | 1 | 1 | -233 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.1% | 19 | 1.0 | 3.9 | 4 | 0 | 1 | 1 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.2m | 0.3% | 19 | 2.8 | 3.7 | 7 | 1 | 0 | -13 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.3m | 3.3% | 18 | 1.0 | 4.2 | 0 | 0 | 0 | -1,955 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.4% | 18 | 0.0 | 4.0 | 0 | 0 | 0 | -56 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 18 | 2.2 | 4.1 | 5 | 0 | 0 | 302 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.4% | 18 | 2.0 | 3.3 | 1 | 1 | 1 | -74 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.1% | 18 | 1.5 | 3.3 | 1 | 0 | 2 | -20 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.5m | 0.1% | 18 | 0.8 | 3.3 | 2 | 0 | 0 | 6 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 0.2% | 18 | 1.2 | 3.4 | 3 | 1 | 0 | -18 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.3% | 17 | 3.2 | 3.9 | 7 | 0 | 0 | 263 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 8.0% | 17 | 1.0 | 2.7 | 2 | 0 | 0 | -1,086 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.2m | 4.0% | 17 | 2.2 | 3.3 | 0 | 0 | 1 | -1,103 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.9m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -52 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.7m | 0.4% | 16 | 0.2 | 3.4 | 0 | 1 | 1 | -80 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -21 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.1% | 16 | 1.2 | 3.3 | 0 | 0 | 1 | -8 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.1% | 16 | 1.0 | 2.9 | 2 | 2 | 0 | -34 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £6.1m | 1.1% | 16 | 2.5 | 2.6 | 4 | 0 | 1 | -18 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 1.2% | 16 | 1.0 | 3.4 | 0 | 0 | 0 | -143 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.6m | 4.6% | 16 | 0.0 | 3.5 | 0 | 0 | 1 | -1,899 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.3% | 16 | 1.8 | 3.6 | 6 | 0 | 0 | 25 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 16 | 0.8 | 2.6 | 2 | 1 | 0 | -73 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.5m | 1.1% | 15 | 3.0 | 2.3 | 1 | 0 | 0 | 535 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 1.0% | 15 | 2.2 | 2.8 | 1 | 0 | 0 | -351 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 15 | 1.2 | 3.1 | 1 | 1 | 0 | -31 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.8m | 0.1% | 15 | 0.8 | 2.6 | 0 | 0 | 0 | -24 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.9m | 0.0% | 15 | 1.8 | 3.1 | 0 | 0 | 0 | -5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.5% | 15 | 2.2 | 3.4 | 3 | 0 | 0 | 16 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.7% | 15 | 3.2 | 3.1 | 2 | 0 | 0 | 75 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.7% | 15 | 0.8 | 2.8 | 1 | 0 | 0 | -29 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 14 | 0.8 | 2.6 | 1 | 0 | 0 | -81 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 14 | 3.2 | 2.9 | 0 | 0 | 0 | 40 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.4m | 0.1% | 14 | 1.5 | 2.6 | 0 | 0 | 1 | -8 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.2m | 0.4% | 14 | 0.8 | 2.7 | 0 | 0 | 2 | -51 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.2% | 14 | 1.0 | 2.9 | 1 | 0 | 1 | -13 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 14 | 2.5 | 2.6 | 2 | 0 | 1 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 14 | 0.8 | 2.6 | 0 | 0 | 1 | -30 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.7m | 0.1% | 14 | 1.5 | 3.0 | 1 | 0 | 0 | 12 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.1% | 14 | 0.2 | 2.6 | 0 | 0 | 0 | -13 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 14 | 3.5 | 3.2 | 12 | 1 | 1 | 5,930 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.7m | 0.9% | 14 | 0.0 | 3.0 | 0 | 0 | 0 | -242 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.1% | 13 | 1.0 | 2.4 | 0 | 0 | 1 | -14 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 0.1% | 13 | 3.0 | 2.2 | 2 | 1 | 0 | 54 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.1% | 13 | 0.5 | 2.7 | 1 | 0 | 0 | -17 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.1% | 13 | 0.2 | 2.9 | 0 | 0 | 0 | -37 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.3% | 13 | 2.5 | 2.7 | 0 | 0 | 0 | -16 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 13 | 0.8 | 2.6 | 0 | 1 | 0 | -14 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.0% | 13 | 0.0 | 2.4 | 0 | 0 | 1 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.4% | 13 | 1.0 | 2.5 | 0 | 0 | 1 | -105 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.5% | 13 | 1.0 | 2.7 | 0 | 0 | 0 | 2 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.6m | 1.1% | 13 | 0.2 | 2.3 | 1 | 1 | 0 | 12 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.7m | 2.8% | 13 | 2.0 | 2.3 | 8 | 0 | 0 | 17 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.1m | 1.1% | 12 | 0.0 | 2.4 | 0 | 0 | 0 | -140 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 0.4% | 12 | 1.5 | 2.1 | 1 | 0 | 0 | -42 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.8% | 12 | 1.8 | 1.9 | 2 | 0 | 0 | -98 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.0% | 12 | 3.0 | 2.2 | 2 | 1 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 1.0% | 12 | 1.8 | 2.4 | 2 | 0 | 0 | -24 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.8% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | -280 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 3.0% | 12 | 0.0 | 2.9 | 0 | 0 | 1 | -1,045 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.2% | 12 | 2.5 | 2.4 | 0 | 0 | 0 | -26 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £7.0m | 2.9% | 11 | 1.8 | 1.6 | 0 | 0 | 1 | -348 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.0m | 0.1% | 11 | 1.8 | 1.8 | 1 | 0 | 1 | -54 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.0% | 11 | 2.5 | 2.3 | 0 | 1 | 0 | -28 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.4m | 0.8% | 11 | 0.2 | 2.0 | 0 | 0 | 0 | -366 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 11 | 2.5 | 2.5 | 1 | 0 | 0 | 12 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 11 | 0.8 | 2.6 | 2 | 1 | 0 | 4 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.8m | 0.8% | 11 | 0.8 | 1.9 | 0 | 0 | 1 | -241 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.8m | 0.9% | 11 | 0.0 | 1.6 | 0 | 0 | 0 | -264 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.1% | 11 | 0.2 | 1.9 | 0 | 1 | 0 | -8 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.4m | 0.3% | 11 | 0.2 | 1.7 | 1 | 0 | 0 | -125 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.7% | 10 | 0.2 | 2.3 | 0 | 0 | 0 | -235 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.8m | 0.7% | 10 | 1.0 | 1.7 | 1 | 0 | 0 | -165 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.5% | 10 | 2.0 | 1.9 | 0 | 0 | 0 | -93 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 10 | 0.2 | 1.9 | 0 | 0 | 0 | -23 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.5% | 10 | 0.0 | 2.1 | 0 | 1 | 0 | -200 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 10 | 1.2 | 1.9 | 0 | 0 | 0 | -7 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.5m | 0.4% | 10 | 0.0 | 1.5 | 0 | 0 | 0 | -60 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £3.9m | 0.5% | 10 | 1.2 | 2.6 | 0 | 0 | 0 | 4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.5% | 10 | 1.2 | 2.1 | 0 | 0 | 0 | -73 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.2m | 1.3% | 10 | 0.5 | 2.4 | 1 | 0 | 0 | -419 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 10 | 0.0 | 1.9 | 0 | 0 | 0 | -63 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 0.2% | 10 | 2.2 | 2.3 | 5 | 0 | 0 | 32 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.1% | 9 | 0.5 | 2.0 | 0 | 0 | 0 | -51 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 9 | 0.2 | 2.0 | 0 | 1 | 0 | -45 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 0.0% | 9 | 1.5 | 1.7 | 1 | 0 | 0 | -4 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 0.1% | 9 | 2.2 | 1.8 | 8 | 1 | 0 | 318 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 9 | 2.0 | 2.0 | 0 | 0 | 0 | -657 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.0% | 9 | 1.2 | 1.8 | 1 | 0 | 0 | 3 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 0.1% | 9 | 1.2 | 1.7 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 0.4% | 9 | 0.5 | 2.1 | 1 | 0 | 0 | -8 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.7m | 0.5% | 9 | 0.8 | 1.6 | 0 | 0 | 0 | -102 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.1% | 9 | 0.8 | 1.8 | 0 | 0 | 0 | -33 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.9% | 9 | -0.2 | 1.9 | 0 | 0 | 0 | -65 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.4% | 9 | 0.8 | 2.1 | 0 | 0 | 1 | -16 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 9 | 1.5 | 1.6 | 0 | 0 | 0 | -5 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.3m | 0.4% | 9 | 1.5 | 1.7 | 0 | 1 | 0 | 30 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.7% | 9 | 0.8 | 1.6 | 1 | 0 | 0 | -95 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.2m | 0.1% | 9 | 2.0 | 1.7 | 3 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 8 | 0.5 | 1.7 | 1 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.8m | 0.1% | 8 | 0.2 | 1.7 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.7% | 8 | 0.8 | 1.7 | 1 | 0 | 0 | -93 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 8 | 0.0 | 1.8 | 0 | 1 | 0 | -53 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.0% | 8 | 1.8 | 1.5 | 1 | 0 | 1 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.2% | 8 | 1.8 | 1.8 | 4 | 0 | 0 | 9 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.8m | 0.1% | 8 | 1.2 | 1.7 | 1 | 0 | 0 | -15 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 8 | 0.8 | 1.7 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.2% | 8 | 0.8 | 1.6 | 0 | 0 | 0 | -176 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £6.9m | 1.0% | 8 | 0.0 | 1.2 | 0 | 1 | 0 | -168 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.8m | 0.1% | 8 | 0.2 | 1.4 | 0 | 0 | 0 | -10 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £3.9m | 1.0% | 8 | 0.2 | 2.1 | 0 | 1 | 0 | -174 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 8 | 1.2 | 1.7 | 0 | 0 | 0 | -3 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.2m | 0.4% | 7 | 0.5 | 1.3 | 0 | 0 | 0 | -201 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 7 | 1.8 | 1.6 | 7 | 0 | 0 | 41 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.3m | 0.8% | 7 | 1.8 | 1.0 | 1 | 0 | 1 | 420 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.2m | 0.1% | 7 | 0.8 | 1.3 | 1 | 0 | 0 | -4 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.4% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | -59 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.3m | 0.1% | 7 | 0.0 | 1.3 | 0 | 0 | 1 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 7 | 0.8 | 1.3 | 2 | 0 | 0 | -7 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.8m | 0.1% | 7 | 0.0 | 1.5 | 1 | 1 | 0 | -20 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.7m | 0.3% | 7 | 0.2 | 1.5 | 0 | 0 | 0 | -46 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.1% | 7 | 0.2 | 1.3 | 1 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.3m | 0.0% | 7 | 0.2 | 1.3 | 0 | 0 | 1 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -16 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.0m | 0.2% | 6 | 0.5 | 1.0 | 0 | 0 | 0 | 24 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -11 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.3% | 6 | 0.8 | 1.1 | 0 | 0 | 0 | -19 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 6 | 0.5 | 1.4 | 0 | 0 | 0 | -15 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.1% | 6 | 0.2 | 1.1 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.5% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -188 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.1% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 6 | 1.2 | 1.2 | 0 | 0 | 1 | -3 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 0.0% | 6 | 1.0 | 1.1 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.0% | 6 | 1.2 | 1.1 | 0 | 0 | 0 | -13 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.2m | 0.7% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -46 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 5 | 1.0 | 1.0 | 1 | 0 | 0 | -15 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.1% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | 9 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 0.0% | 5 | 0.8 | 0.9 | 0 | 0 | 0 | 0 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.2m | 0.0% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | -2 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -8 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.1% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -15 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.4% | 5 | 0.5 | 1.3 | 0 | 0 | 0 | 61 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.0% | 5 | 0.2 | 1.3 | 1 | 0 | 0 | -152 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.1% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 5 | 0.2 | 1.0 | 1 | 0 | 1 | 29 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 5 | 0.5 | 1.1 | 1 | 0 | 0 | 1 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 5 | 0.2 | 0.9 | 0 | 0 | 0 | -14 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.2% | 4 | 0.0 | 0.7 | 0 | 0 | 0 | -31 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.7m | 0.3% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -13 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -12 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 0.1% | 4 | 0.2 | 0.8 | 0 | 0 | 0 | -7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.4% | 4 | 0.0 | 1.0 | 0 | 0 | 0 | -96 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 5.4% | 4 | 0.2 | 0.9 | 0 | 0 | 0 | -1,119 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | -11 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.1m | 1.1% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -181 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 0.4% | 4 | 0.0 | 0.7 | 0 | 0 | 1 | -36 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.7m | 0.1% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -79 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.8m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 1.0% | 4 | 1.0 | 0.9 | 1 | 0 | 0 | -175 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.5m | 0.1% | 4 | 0.8 | 0.6 | 0 | 0 | 0 | -56 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -8 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 3.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -629 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.0% | 3 | 0.2 | 0.6 | 1 | 0 | 0 | -3 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.2m | 0.0% | 3 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.3m | 1.1% | 3 | 0.0 | 0.5 | 0 | 0 | 0 | -225 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -30 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -8 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.6% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | -39 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -16 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.2m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -90 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 3 | 0.5 | 0.6 | 1 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 0.9% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -145 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 3 | 0.5 | 0.7 | 1 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | -2 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | 7 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.0m | 0.0% | 3 | 0.5 | 0.5 | 1 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.1% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | 25 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -6 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.3m | 0.1% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -40 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.2m | 0.1% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | -20 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.1% | 2 | 0.5 | 0.4 | 1 | 0 | 0 | -38 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 6 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -5 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.5% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -83 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.2m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -85 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.4% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -59 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.0% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -3 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.5% | 2 | 0.2 | 0.5 | 1 | 0 | 0 | -63 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 2.5% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -1,181 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.3m | 0.2% | 2 | 0.2 | 0.5 | 0 | 0 | 0 | -29 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.1% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -34 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 0.2% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -61 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.9m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -43 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 1 | 0.2 | 0.2 | 1 | 0 | 0 | 225 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -7 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -8 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -39 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -41 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -47 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.8m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 21 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 36 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 5 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.0% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -10 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -231 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £3.9m | 0.2% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 33 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -37 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | -20 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -244 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 505 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -12 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -347 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -83 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.8m | 2.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -129 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -73 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 6 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -720 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -188 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 5 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -20 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £3.9m | 3.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -643 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -25 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -65 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -20 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -174 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -36 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -157 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -207 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -22 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -382 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -212 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 4.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,171 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -12 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -126 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 1.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -156 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -33 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 19 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -37 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -700 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -97 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £3.9m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -95 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -39 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -15 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -39 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -169 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -166 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 30 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -73 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.1m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -54 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 9 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 11 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 158 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -194 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -71 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -83 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -24 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -70 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -22 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -199 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £3.9m | 15.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3,168 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -171 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -206 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 11 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) |